UBXN11 and vascular disorder: The ROR signal intensity linked to cetuximab at the SOC level was significantly higher than that of panitumumab when considering “cardiac diseases”, “immune system disorders”, “respiratory, thoracic, and mediastinal disorders” and “vascular disorders”, was significantly higher than that of panitumumab.